Invitrogen™ SARS-CoV-2 NSP10 Recombinant Protein

Catalog No.	Quantity
PIRP88282	100 μg

Catalog No. PIRP88282 Supplier Invitrogen™ Supplier No. RP88282

Description

Recombinant Protein

It is recommended that the protein be aliquoted for optimal storage. It is recommended that sterile water (400 μL) be added to the vial to prepare a stock solution of 0.25 mg/mL. Concentration is measured by UV.

Severe Acute Respiratory Syndrome (SARS), an emerging disease characterized by atypical pneumonia, has recently been attributed to a novel coronavirus (SARS-CoV). The nucleocapsid protein (N) was one of the structural proteins of SARS-CoV (N, S, sE, M). The severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid (N) protein is the most abundant protein in the virus-infected cells. The SARS-CoV-2 S gene has 76% amino acid similarity to the SARS-CoV S gene, and nonsynonymous mutations developed in the S protein as the SARS-CoV epidemic developed, reports have shown that the crystal structure of the SARS-CoV-2 nucleocapsid protein is similar to those of previously described coronavirus N proteins, but their surface electrostatic potential characteristics are distinct.

Specifications

• For Use With (Application): Control, Neutralization
• Format: Lyophilized
• Formulation: 20mM tris with 0.01% mannitol, 500mM NaCl, 5-8% trehalose, 0.01% Tween 80 and no preservative; pH 7.4
• Molecular Weight (g/mol): 15 kDa
• Name: SARS-CoV-2 NSP10
• pH Range: 7.4
• Purification Method: Purified
• Quantity: 100 μg
• Storage Requirements: -20°C, Avoid Freeze/Thaw Cycles
• Regulatory Status: RUO
• Gene Alias: CoV; CoV-2; NSP10; SARS
• Common Name: SARS-CoV-2 NSP10
• Product Type: Protein
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Sequence: SARS-CoV-2 NSP10, amino acids Ala1-Gln139 (Accession # YP_009725306.1) with an N-terminal GP
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Expression System: E. coli
• Form: Lyophilized
• Purity or Quality Grade: >95% as determined by SDS-PAGE.